Pharmaceutical firms are moving more towards healthcare-oriented organizations as they collaborate with many different partners with interests that extend beyond just the medical solution. These partners include telecommunication and engineering companies for technology; patient communities and advocacy groups for services; and food and fitness businesses and associations for lifestyle approaches. The result will be the capability of delivering more complex, integrated solutions that can be tailored to the specific needs of a modern, more educated patient base.
The ability to manage structured and unstructured data of different types to generate new insights and outcomes constitutes a true competitive advantage for organizations that build more patientcentric and interactive information platforms. Integrated and interoperable informatics applications with advanced tools for identifying data trends and patterns can be used to develop more predictive and preventative approaches, especially when the generated knowledge can be harvested back into a unified, collaborative workflow ecosystem. This new R&D environment is moving the pharmaceutical industry into a new era of predictive sciences extending across the complete value chain of the continuum of care.
Learn how having the right predictive sciences capabilities integrated into R&D work flows delivers a scientific decision support environment that reduces time and expense, improves quality, enhances collaboration and accelerates innovation in bringing new drugs to market.